We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

28 hedge funds and large institutions have $5.74M invested in ImmuCell in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

1.19% more ownership

Funds ownership: 13.35% → 14.54% (+1.2%)

5% more capital invested

Capital invested by funds: $5.47M → $5.74M (+$269K)

7% less funds holding

Funds holding: 30 → 28 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
10
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$397K
2
Northern Trust
Northern Trust
Illinois
+$96.5K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$78.9K
4
MFIM
Mesirow Financial Investment Management
Illinois
+$59.4K
5
Renaissance Technologies
Renaissance Technologies
New York
+$23.5K

Top Sellers

Rank Fund Capital Flow
1
PCM
Perritt Capital Management
Illinois
-$144K
2
Citadel Advisors
Citadel Advisors
Florida
-$77.5K
3
HL
HeadInvest LLC
Maine
-$16.3K
4
BlackRock
BlackRock
New York
-$4.48K
5
US Bancorp
US Bancorp
Minnesota
-$3.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.05M +$7.36K +1,509 +0.7%
Morgan Stanley
2
Morgan Stanley
New York
$861K +$397K +81,274 +92%
Renaissance Technologies
3
Renaissance Technologies
New York
$642K +$23.5K +4,809 +4%
CAM
4
Cresset Asset Management
Illinois
$523K – – –
BL
5
Bleichroeder LP
New York
$517K – – –
SRC
6
Shufro Rose & Co
New York
$333K – – –
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$290K -$698 -143 -0.2%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$269K – – –
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$170K +$78.9K +16,164 +92%
OMC
10
Overbrook Management Corp
New York
$167K – – –
Northern Trust
11
Northern Trust
Illinois
$166K +$96.5K +19,781 +154%
SFS
12
Strategic Financial Services
New York
$157K – – –
HighTower Advisors
13
HighTower Advisors
Illinois
$108K – – –
PP
14
Prosperity Planning
Missouri
$81.4K – – –
BlackRock
15
BlackRock
New York
$79K -$4.48K -918 -6%
WE
16
Wealth Effects
Massachusetts
$78.5K -$976 -200 -1%
MFIM
17
Mesirow Financial Investment Management
Illinois
$62K +$59.4K +12,178 New
EFS
18
Essex Financial Services
Connecticut
$56K – – –
MWM
19
Mission Wealth Management
California
$50.9K – – –
HPC
20
HM Payson & Co
Maine
$30.3K – – –
Wells Fargo
21
Wells Fargo
California
$12.9K +$12.2K +2,502 +6,255%
TRCT
22
Tower Research Capital (TRC)
New York
$10.5K +$2.09K +429 +26%
Bank of America
23
Bank of America
North Carolina
$10.4K +$15 +3 +0.1%
UBS Group
24
UBS Group
Switzerland
$7.63K -$468 -96 -6%
Osaic Holdings
25
Osaic Holdings
Arizona
$2.8K +$2.68K +550 New
1
2

ICCC Hedge Fund Activity: Q4 2023 in Review

28 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2023, worth a combined $5.74M — up 4.9% from $5.47M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ICCC and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 10 added.

The largest buyer was Morgan Stanley, adding an estimated $397K. The largest seller was Perritt Capital Management, exiting entirely with an estimated $144K sold.

  • 28 institutional investors held ImmuCell (ICCC) as of Q4 2023, down from 30 in Q3 2023.
  • Funds reported $5.74M of ImmuCell stock for Q4 2023, up 4.9% quarter-over-quarter.
  • 2 funds opened new ImmuCell positions in Q4 2023 and 4 closed out, a net change of -2 holders.
  • The largest ImmuCell buyer in Q4 2023 was Morgan Stanley, an estimated $397K added.
  • The largest ImmuCell seller in Q4 2023 was Perritt Capital Management, an estimated $144K sold.

Based on aggregated 13F filings for Q4 2023.